Cheongdam-dong 18-20, #B01
Gangnam-gu
Seoul 135-949
South Korea
https://www.cmgpharma.co.kr
Secteur(s):
Secteur d’activité:
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Joohyung Lee | Chief Executive Officer | S.O. | S.O. | S.O. |
Joong-Hwan Bae | Head of Management Supporting Team and Director | S.O. | S.O. | 1954 |
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
L’ISS Governance QualityScore de CMG Pharmaceutical Co., Ltd. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..